A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
The study is intended to test efficacy, safety and tolerability of two doses of Mirabegron against placebo and compare the efficacy and safety with active comparator in patients with symptoms of overactive bladder.
Inclusion Criteria:
Exclusion Criteria:
Leper, 8900, Belgium
Ostrava-Poruba, 70853, Czechia
Henningsdorf, 16761, Germany
Muenchen-Bogenhausen, 81925, Germany
Nikaias-Piraeus, Greece
Lasi, Romania
Esplugues de Llobregat-Barcelo, 08950, Spain